Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — ZETAGEN THERAPEUTICS, INC.

0001730728-25-000003 · filed Nov 12, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$12,999,998
Reported amount sold
$12,908,022
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
ZETAGEN THERAPEUTICS, INC.
CIK
1730728
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
841 EAST FAYETTE STREET
SYRACUSE, New York 13210
Phone
315-475-2200

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗